Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease

Clinical trial NCT03893240 · COMPLETED

Trial details

NCT number: NCT03893240
Sponsor: Spark Therapeutics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pompe Disease Pompe Disease (Late-onset)Glycogen Storage Disease Type 2 LOPD Lysosomal Storage Diseases Acid Maltase Deficiency

Start date: 2019-06-12
Primary completion: 2020-10-27
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.